drug
inebilizumab
Marketedupdated 6mo agoby Horizon Therapeutics USA Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 1all catalysts(0)
nothing on the calendar yet
Trials studying inebilizumab
- phase2A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
- phase2A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)
- phase3A Phase 3 Study of Inebilizumab in Participants With Primary Membranous Nephropathy
- —AMG 335 Expanded Access Program for IgG4-Related Disease
- —Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy
- phase3Myasthenia Gravis Inebilizumab Trial
- phase2Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Inebilizumab in Pediatric Participants With IgG4-RD
- phase3A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease
News(4)
- Amgen starts MariTide autoinjector study as pivotal readouts approachWith the first Phase 3 data expected for Amgen’s MariTide next year, analysts are looking for evidence that the GLP-1 candidate is tolerable. Meanwhile, the company has begun testing an autoinjecto…biospace · 12d ago
- Amgen’s Horizon-acquired fusion protein eases Sjögren's severity in ph. 3 winAn investigational drug for the autoimmune condition Sjögren's disease has scored a phase 3 win for Amgen, marking a positive sign for the Horizon Therapeutics-acquired pipeline that has so far str…fiercebiotech · 1mo ago
- New data could widen use of AstraZeneca, Amgen immune disease drugTezspire succeeded in a study in eosinophilic esophagitis, which could become the drug’s third approved indication and unlock what’s viewed as a blockbuster opportunity.biopharma_dive · 2mo ago
- Amgen’s MariTide stands alone after obesity cull while analysts seek more M&AAmgen has discontinued Phase 1 obesity candidate AMG 513, leaving MariTide as its sole weight loss asset. Meanwhile, executives said the company’s late-stage pipeline is largely full and future bus…biospace · 3mo ago
Data sources
last refreshed 5h ago
Found something off?
comments(0)
5-min edit window · permanent after that